SIRT1 and ulcerative colitis: These results could be explained by the fact that the regulated gut microbiota in the intervention group did not allow for a reduction in SIRT1 expression that occurred in the placebo group, which is supported by the literature finding that gut tissues from patients with a disturbed gut microbiota, such as in ulcerative colitis, expressed significantly lower levels of SIRT1 than healthy controls [47].